Vaccine hesitancy in the French population in 2016 and its association with vaccine uptake and perceived vaccine risk-benefit balance

Dominique Rey (1) , Lisa Fressard (2, 1) , Sebastien Cortaredona (3) , Aurelie Bocquier (3, 1) , Arnaud Gautier (4, 5) , Patrick Peretti-Watel (3, 1) , Pierre Verger (3, 1)

1 ORS PACA - Observatoire régional de la santé Provence-Alpes-Côte d'Azur [Marseille]
2 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
3 VITROME - Vecteurs - Infections tropicales et méditerranéennes
4 Département sciences de Gestion
5 Santé publique France - French National Public Health Agency [Saint-Maurice, France]

BackgroundVaccine hesitancy (VH) is prominent in France. Objectives: This study aimed to estimate the prevalence and socio-demographic correlates of VH in sub-groups of the French population and to investigate the association of VH with both vaccine uptake and perceived risk-benefit balance (RBB) for four vaccines. Methods: During the 2016 Health Barometer - a national cross-sectional telephone survey in a representative sample of the French population - parents of 1-15 year-old children, parents of 11-15 year-old girls and elderly people aged 65-75 years were asked about VH (using three questions adapted from the World Health Organization definition), vaccine uptake and perceived RBB for measles and hepatitis B (children's parents), human papillomavirus (girls' parents) and seasonal influenza (elderly people) vaccines. Results: A total of 3,938 parents including 959 girls' parents - and 2,418 elderly people were interviewed. VH prevalence estimates were 46% (95% confidence interval (CI): 44-48) among parents, 48% (95%CI: 45-51) among girls' parents and 35% (95% CI: 33-36) among elderly people, with higher estimates associated with high education level, children's age (10-15 years), and, for the elderly, poor perception of health status. VH was associated with uncertainty about and/or an unfavourable perception of vaccines' RBB for the four vaccines and with lower self-reported vaccine uptake, except for human papillomavirus vaccine in girls. Results were confirmed by multivariable analysis. Conclusion: Further research is needed to study the association between VH and vaccine uptake for other vaccines, and to design and validate measurement tools to monitor VH over time.

Mots clés: human papillomavirus vaccine; measles vaccine; hepatitis B vaccine; seasonal influenza vaccine; vaccine hesitancy

Domaines: Maladies infectieuses

Dominique Rey, Lisa Fressard, Sebastien Cortaredona, Aurelie Bocquier, Arnaud Gautier, et al.. Vaccine hesitancy in the French population in 2016 and its association with vaccine uptake and perceived vaccine risk-benefit balance. Eurosurveillance, 2018, 23 (17), pp.30-39. ⟨10.2807/1560-7917.ES.23.17.17-00816⟩. ⟨hal-01826771⟩